Effects of glutamine supplementation on circulating lymphocytes after bone marrow transplantation: A pilot study

American Journal of the Medical Sciences

Volumn 315, Issue 1, 1998, Pages 4-10

  Ziegler, Thomas R ^a   Bye Rd, Rangy L ^a   Rebecca, L ^a   Persinger, R D ^a   Lorraine, S ^a   Young, R D ^a   Antin, Joseph H ^a   Wilmore, Douglas W ^a,b,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c EMORY CLINIC   (United States)

Author keywords

Bone marrow transplantation; Glutamine; Lymphocytes; Parenteral nutrition

Indexed keywords

AMINO ACID; GLUTAMINE; METHOTREXATE; RENAMINE; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HELPER CELL; HODGKIN DISEASE; HOSPITALIZATION; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; LYMPHOCYTE; MALE; MONONUCLEAR CELL; PARENTERAL NUTRITION; POSTOPERATIVE INFECTION; SUPPRESSOR CELL;

EID: 0031974395     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-199801000-00002     Document Type: Article

References (31)

1. American Society for Parenteral and Enterai Nutrition Board of Directors. Guidelines for the use of parenteral and enterai nutrition in adult and pédiatrie patients. JPEN J Parent Enterai Nutr. 1993;14(suppl 4):1SA-52SA.
2. American College of Physicians. Parenteral nutrition in patients receiving cancer chemotherapy. Ann Intern Med. 1989; 110:734-6.
3. Pomposelli JJ, Bistrian BR. Is total parenteral nutrition immunosuppressive? New Horiz. 1994; 2:224-9.
4. Alverdy JC, Chi HS, Sheldon GF. The effect of parenteral nutrition on gastrointestinal immunity: The importance of enterai stimulation. Ann Surg. 1985;202:681-4.
5. Mainous MR, Deitch EA. Bacterial translocation and its potential role in the pathogenesis of multiple organ failure. J Intensive Care Med. 1992; 7:101-8.
6. DeBiasse MA, Wilmore DW. What is optimal nutritional support? New Horiz. 1994; 2:122-30.
7. Ziegler TR, Young LS. Therapeutic effects of specific nutrients. In: Rombeau JL, Rolandelli RH, eds. Clinical Nutrition: Enterai and Tube Feeding. 3rd ed. Philadelphia: WB Saunders; 1996:112-37.
8. Ziegler TR. Glutamine supplementation in catabolic illness. Am J Clin Nutr. 1996;64:645-7.
9. Ziegler TR, Benfell K, Smith RJ, Young LS, Brown E, Ferrari-Baliviera E, et al. Safety and metabolic effects of L-glutamine administration in humans. JPEN J Parent EnteralNutr. 1990; 14:1378-463.
10. Souba WW. Intestinal glutamine metabolism and nutrition. J Nutr Biochem. 1993;4:2-9.
11. Fox AD, Kripke SA, DePaula J, Settle R, Rombeau JR. Effect of glutamine-supplemented enterai diet on methotrexate-induced enterocolitis. JPEN J Parenter Enterai Nutr. 1988; 12:325-1.
12. Klimberg VS, Salloum R, Kasper M, Souba WW. Oral glutamine accelerates healing of the small intestine and improves outcome following whole abdominal radiation. Arch Surg. 1990;125:1040-5.
13. Klimberg VS, Souba WW, Dolson DJ. Prophylactic glutamine protects the intestinal mucosa from radiation injury. Cancer. 1990;60:62-8.
14. Ziegler TR, Young LS, Benfell K, Scheltinga M, Ilortos K, Bye R, et al. Clinical and metabolic efficacy of glutaminesupplemented parenteral nutrition after bone marrow transplantation: A randomized, double-blind, controlled study. Ann Intern Med. 1992; 116:821-8.
15. Tremel H, Kienle B, Weilemann LS, Stehle P, Fürst P. Glutamine dipeptide supplemented TPN maintains intestinal function in the critically ill. Gastroenterology. 1994; 107:1595-1601.
16. Van Der Hülst RRW, Van Kreel BK, Von Meyenfeldt MF, Brummer RJM, Arends JW, Deutz NEP, et al. Glutamine and the preservation of gut integrity. Lancet. 1993;341:1363-5.
17. Skubitz KM, Andcrson PM. Oral glutamine to prevent chemotherapy induced stomatitis: A pilot study. J Lab Clin Med. 1996; 127:223-8.
18. Ardawi MSM, Newsholme EA. Intracellular localization and properties of phosphate-dependent glutaminase in rat mesenteric lymph nodes. Biochem J. 1984;217:289-96.
19. Ardawi MSM. Glutamine and glucose metabolism in human peripheral lymphocytes. Metabolism. 1988;37:99-103.
20. Calder PC. Glutamine and the immune system. Clin Nutr. 1994;13:2-8.
21. Crawford J, Cohen HJ. The essential role of L-glutamine in lymphocyte differentiation in vitro. J Cell Physiol. 1985;124:275-82.
22. Kafkewitz D, Bendich A. Enzyme-induced asparagine and glutamine depletion and immune system dysfunction. Am J Clin Nutr. 1983;37:1025-30.
23. Parry-Billings M, Evans J, Calder PC, Newsholme EA. Does glutamine contribute to immunosuppression after major burns? Lancet. 1990;336:523-5.
24. Ogle CK, Ogle JD, Mao JX. Effect of glutamine on phago-cytosis and bacterial killing by normal and pédiatrie burn patient neutrophils. JPEN J Parenter Enterai Nutr. 1994; 18:128-33.
25. Alverdy JA, Aoys E, Weiss-Carrington P. The effect of glutamine-enriched TPN on gut immune cellularity. J Surg Res. 1992;52:34-8.
26. Ault KA, Antin JH, Ginsburg D. Phenotype of recovery lymphoid cell population after marrow transplantation. J Exp Med. 1985;161:1483-502.
27. O'Riordain MG, Fcaron KCH, Ross JA, Rogers P, Falconer JS, Bartolo DCC, et al. Glutamine-supplemented total parenteral nutrition enhances T-lymphocyte response in surgical patients undergoing colorectal resection. Ann Surg 1994;220:212-21.
28. Jensen GL, Miller RH, Talabiska DG, Fish J, Gianfera-nte L. A double-blind prospective study of glutamine-enriched versus standard peptide-based feeding in the critically ill. Am J Clin Nutr. 1996;64:645-51.
29. Schloerb PR, Amare M. Total parenteral nutrition with glutamine in bone marrow transplantation and other clinical applications (à randomized, double-blind study). JPEN J Parenter Enterai Nutr. 1993; 17:407-13.
30. van Zaaen HOT, van der Lelie H, Timmcr JG. Parenteral glutamine dipeptide supplementation does not ameliorate chemotherapy-induced toxicity. Cancer. 1994; 74:2879-84.
31. Roig JC, Bowling D, Dallas M, Sleasman J, Aucstad N, Neu J. Enterai glutamine supplementation decreases nosocomial infection and alters T-cell subset in the very low birth weight (VLBW) (<1250 gram) neonate (abstract). Pediatr Res. 1995;37:285A.